Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Perspective Therapeutics's enterprise value was -$141.22M on Nov 11, 2026, against $2.18M a year earlier. Over the last 5 years it ranged from -$141.22M to $774.07M, with a median of $19.39M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$141.22M | -542.5% |
| 2025 | Dec 31, 2025 | $31.91M | – |
| 2024 | Dec 31, 2024 | -$50.64M | -4284.2% |
| 2023 | Dec 29, 2023 | $1.21M | – |
| 2022 | Dec 30, 2022 | -$20.38M | – |
| 2021 | Dec 31, 2021 | -$6.66M | -122.9% |
| 2020 | Dec 31, 2020 | $29.06M | -22.5% |
| 2019 | Dec 31, 2019 | $37.50M | +240.7% |
| 2018 | Dec 31, 2018 | $11.01M | -25.2% |
| 2017 | Dec 29, 2017 | $14.71M | -19.2% |
| 2016 | Dec 30, 2016 | $18.20M | -52.4% |
| 2015 | Dec 31, 2015 | $38.23M | -43.8% |
| 2014 | Dec 31, 2014 | $68.03M | +388.5% |
| 2013 | Dec 31, 2013 | $13.93M | -36.6% |
| 2012 | Dec 31, 2012 | $21.96M | +38.2% |
| 2011 | Dec 30, 2011 | $15.89M | – |
See a number that looks wrong?